Pfizer will start testing Covid-19 vaccine booster doses in children aged six months to five years old after finding that its lower-dose shot may not provide enough protection in one age group. The pharmaceutical giant announced on Thursday that it would start testing a third dose on young children “at least two months after the second dose” in an effort “to provide high levels of protection in this young age group.” Explaining its decision, the company cited clinical data showing that the smallest ‘baby’ dose administered to children under five does not appear to be effective in protecting those in …read more
Source: Sott health news feed
Thanks! Share it with your friends!
Tweet
Share
Pin It
LinkedIn
Google+
Reddit
Tumblr